Use of the phytocannabinoid cannabidiol (cbd) in combination with a standard anti-epileptic drug (saed) in the treatment of epilepsy

摘要

Provided is a combination of cannabidiol (CBD), at a dose greater than 300mg/day or 16 mg/kg, and a standard anti-epileptic drug (SAED) which acts via sodium or calcium channels for the treatment of epilepsy. The preferred SAEDs are ethosuximide, valproate and phenobarbital.